Singapore Clinical Trial: A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, multi-center study, with a primary efficacy endpoint at 12 weeks, to determine the efficacy, safety, and tolerability of fixed doses of 15 mg bid and 30 mg bid of evenamide as add-on in patients with documented treatment-resistant schizophrenia, which is not adequately controlled by a stable therapeutic dose of the patient’s current antipsychotic medication(s).

Singapore, July 21 -- The Health Sciences Authority received information related to the study titled 'A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, m... Read More

Singapore Clinical Trial: A Phase 1, 2-Part Study to Determine the Effect of Injection Site on the Relative Bioavailability of a Single Subcutaneous Dose of LY3537031 and to Evaluate the Pharmacokinetics of a Single Intravenous Dose of LY3537031 in Healthy Participants

Singapore, July 21 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, 2-Part Study to Determine the Effect of Injection Site on the Relative Bioavailability ... Read More

Singapore Clinical Trial: A Phase 3 Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT (Sacituzumab Tirumotecan, MK-2870) Followed by Carboplatin/Paclitaxel vs Chemotherapy, Both in Combination With Pembrolizumab as Neoadjuvant Therapy for High-Risk, Early-Stage, Triple-Negative Breast Cancer or Hormone Receptor-low Positive/Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer

Singapore, July 21 -- The Health Sciences Authority received information related to the study titled 'A Phase 3 Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT (Sacituzumab... Read More

Singapore Clinical Trial: A Global, Phase 3, Randomized, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Firmonertinib Compared with Investigator’s Choice of Osimertinib or Afatinib as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic Non-Small-Cell Lung Cancer with Epidermal Growth Factor Receptor P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations (ALPACCA)

Singapore, July 21 -- The Health Sciences Authority received information related to the study titled 'A Global, Phase 3, Randomized, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety o... Read More

Singapore Clinical Trial: A Phase 2 Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MK-2214 in Participants with Early Alzheimer's Disease

Singapore, July 21 -- The Health Sciences Authority received information related to the study titled 'A Phase 2 Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study to Evaluate the Effic... Read More

Tinubu congratulates Badejo-Okusanya, first elected female NBA president

Nigeria, July 21 -- President Bola Tinubu has congratulated Oyinkansola Badejo-Okusanya, a Senior Advocate of Nigeria (SAN), on her election as the first elected female president of the Nigerian Bar A... Read More

Who is Harmanveer Singh? FBI manhunt on amid drug trafficking charges, link to Dhanda gang

India, July 21 -- Following Operation Hard Ball, the Federal Bureau of Investigation is now on the lookout for Harmanveer Singh. Singh has been under the FBI's radar for his alleged role in drug traff... Read More

From John Abraham to Notandas Realty: Why Mumbai's billionaires continue to chase trophy bungalows

India, July 21 -- When Bollywood actor John Abraham acquired a bungalow in Mumbai's Bandra West for Rs.84 crore, it was more than another celebrity real estate transaction, it underscored the enduring... Read More

From John Abraham to Notandas Realty: Why Mumbai's billionaires continue to chase trophy bungalows

India, July 21 -- When Bollywood actor John Abraham acquired a bungalow in Mumbai's Bandra West for Rs.84 crore, it was more than another celebrity real estate transaction, it underscored the enduring... Read More

John Abraham's Rs.84-crore bungalow purchase: Why Mumbai's wealthy continue to chase trophy homes

India, July 21 -- When Bollywood actor John Abraham acquired a bungalow in Mumbai's Bandra West for Rs.84 crore, it was more than another celebrity real estate transaction, it underscored the enduring... Read More

• ««
• «
• 11039
• 11040
• 11041
• 11042
• 11043
• 11044
• 11045
• 11046
• 11047
• 11048
• »
• »»